Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 08:30 ET | Source: Genco Shipping & Trading Limited

Genco Shipping & Trading Limited Announces Delivery of Second High Specification Newcastlemax Vessel This Year

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global...
March 24, 2026 08:00 ET | Source: Imunon, Inc.

IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026

LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the...
March 24, 2026 07:45 ET | Source: NanoXplore Inc.

NanoXplore publie son premier Rapport de durabilité

MONTRÉAL, 24 mars 2026 (GLOBE NEWSWIRE) -- NanoXplore Inc. (« NanoXplore » ou la « Société ») (TSX : GRA et OTCQX : NNXPF), chef de file mondial dans le domaine du graphène, est heureuse...
March 24, 2026 07:45 ET | Source: NanoXplore Inc.

NanoXplore Publishes Its First Sustainability Report

MONTREAL, Quebec, March 24, 2026 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, is pleased to announce the publication of its first...
March 24, 2026 07:00 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

~ Delivered Record Annual Revenue with Full-Year Net PEDMARK® Product Sales of $44.6 Million, Representing 50% Year-Over-Year Growth, and Q4 2025 Net Product Sales of $13.8 Million, Representing 75%...
March 24, 2026 06:45 ET | Source: UTStarcom Holdings Corp.

UTStarcom Reports Unaudited Financial Results for Second Half and Full Year 2025

HANGZHOU, China, March 24, 2026 (GLOBE NEWSWIRE) -- UTStarcom (the Company) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results for...
March 24, 2026 02:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
March 23, 2026 18:25 ET | Source: Galapagos NV

Galapagos en Gilead in vergevorderde gesprekken over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen

Galapagos is van plan een strategische samenwerking aan te gaan met Gilead, na de overname van Ouro Medicines door Gilead De nieuwe partnerstructuur zou aanzienlijk verbeterde financiële voorwaarden...
March 23, 2026 18:25 ET | Source: Galapagos NV

Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms...
March 23, 2026 11:44 ET | Source: Research and Markets

Ferrosilicon Market Poised to Reach $15.4 Billion by 2034 - Asia-Pacific Leads Ferrosilicon Market with Dominant Share and Rising Demand

Dublin, March 23, 2026 (GLOBE NEWSWIRE) -- The "Ferrosilicon Market Report by Type, Application, End User, and Region 2026-2034" has been added to ResearchAndMarkets.com's offering. The global...